Sulfamethoxazole And Trimethoprim Tablet
FDA Recall NDC 55154-7895

FDA Enforcement Report: View Recall Date, Reasons, and Safety Status

Active & Historical Enforcement Reports

The FDA has identified 1 recorded enforcement report(s) associated with Sulfamethoxazole And Trimethoprim (NDC 55154-7895). A significant event, classified as Class II, was initiated on Sep 02, 2025 by Cardinal Health 107, Llc. The reported reason for this action was: "Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets."

This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.

Reported Recall Events

September 2025 Class II Recall: Presence of a Foreign Substance

Recall Number
Class II Ongoing
Reason for Recall
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Initiated
Sep 02, 2025
Reported
Sep 17, 2025
Quantity
N/A

Recall Profile & Regulatory Data

Event ID
97523
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
USA Nationwide.
Product Description
Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 10 Tablets unit dose blister pack (10x1) per bag, Rx only, Distributed by Cardinal Health, Dublin, OH 43017, NDC 55154-7895-0 (Outer Bag) containing NDC 0904-2725-61 (Inner blisters).
Batch or Lot Expiration Information
Lot# Bag: N02309A and N02309B, Exp Date: 03/31/2027; Inner blister:
Lot# N02309, Exp Date: 03/31/2027
Affected Packages Involved in this Recall
55154-7895-0Product
0904-2725-61Product

About FDA Recall Enforcement Reports

FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.

If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.